Key facts
- This page summarizes Laura Carter's Form 4 filing for Gossamer Bio, Inc. (GOSS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2023, 09:22.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $1.08 to $1.10 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.